Liu et al. reported that upregulated transsulfuration pathway for cysteine synthesis in erastin-resistant ovarian cancer cells compensates for cysteine deprivation by xCT blockage, which is mediated by Nrf2-mediated CBS activation (51). The gene discussed is CBS; the disease is ovarian carcinoma.